4d Molecular Therapeutics
Clinical trials sponsored by 4d Molecular Therapeutics, explained in plain language.
-
One shot to save sight? gene therapy trial aims to cut eye injections for wet AMD
Disease control OngoingThis phase 3 trial tests a single injection of 4D-150 gene therapy in 480 adults with wet age-related macular degeneration (AMD). The goal is to see if one treatment can control the disease and reduce the need for regular eye injections over two years. Participants receive either…
Phase: PHASE3 • Sponsor: 4D Molecular Therapeutics • Aim: Disease control
Last updated May 17, 2026 10:26 UTC
-
One-Time gene shot may cut eye injections for diabetic swelling
Disease control OngoingThis study tests a gene therapy called 4D-150 for people with diabetic macular edema, a condition where fluid builds up in the eye and blurs vision. About 72 adults who still need regular eye injections will receive either the gene therapy or standard treatment. The goal is to se…
Phase: PHASE2 • Sponsor: 4D Molecular Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:54 UTC